High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model.

Griffin, Patricia; Hill, Wendy A; Rossi, Fabio; Boohaker, Rebecca; Stinson, Karr; Sherman, Igor

Griffin, Patricia; Hill, Wendy A; Rossi, Fabio; Boohaker, Rebecca; Stinson, Karr; Sherman, Igor.

Afiliação

Griffin P; Biocatalyst4Development Inc., 33 Markham Road, Scarborough, ON, M1M 2Z5, Canada.
Hill WA; Biocatalyst4Development Inc., 33 Markham Road, Scarborough, ON, M1M 2Z5, Canada.
Rossi F; Abzena Ltd., Babraham Research Campus, Cambridge, CB22-3AT, UK.
Boohaker R; Southern Research Institute, 2000 Ninth Avenue South, Birmingham, AL, 35205, USA.
Stinson K; Southern Research Institute, 2000 Ninth Avenue South, Birmingham, AL, 35205, USA.
Sherman I; Alpha Cancer Technologies Inc., MaRS Centre-South Tower, 200-101 College Street, Toronto, ON, M5G 1L7, Canada. isherman@alpha-cancer.com.

Cancer Cell Int ; 23(1): 60, 2023 Apr 05.

Article em En | MEDLINE | ID: mdl-37016369

Palavras-chave

AFP receptor; Alpha-fetoprotein-maytansinoid conjugate; Colorectal cancer; Tumor targeting

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google